SCHEMBL8287429

SCHEMBL8287429

Cc1nc2c(cc1NCC(=O)N(C)C)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 3/20 0.46
HTT P42858 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PDE11A Q9HCR9 1/20 0.36
CSF1R P07333 1/20 0.35
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34
MAPK1 P28482 1/20 0.34
GFER P55789 1/20 0.34
OPRK1 P41145 1/20 0.34
P2RX7 Q99572 1/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RXRA P19793 1/20 0.33
MAPT P10636 1/20 0.32
TNK2 Q07912 1/20 0.32
ALDH1A2 O94788 1/20 0.32
ALDH1A3 P47895 1/20 0.32
SYK P43405 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286429 0.92 MAT2A (0.39) MAT2AHTTKDM4EPDE11ACSF1R
SCHEMBL8287487 0.90 PDE11A (0.38) MAT2AHTTKDM4EPDE11ACSF1R
SCHEMBL8287436 0.89 PDE11A (0.37) MAT2AHTTKDM4EPDE11ACSF1R
SCHEMBL8287555 0.88 KDM4E (0.36) MAT2AHTTKDM4EPDE11ACSF1R
SCHEMBL8362883 0.88 OPRK1 (0.39) MAT2AHTTKDM4EPDE11ACSF1R
SCHEMBL8286432 0.84 KMT2A (0.39) KDM4EPDE11AHPGDALDH1A1SMN1; SMN2
SCHEMBL8287451 0.84 PDE11A (0.42) MAT2AHTTKDM4EPDE11AGAA
SCHEMBL8287426 0.83 CYP3A4 (0.42) MAT2AHTTKDM4EPDE11AMAPK1
SCHEMBL8285208 0.83 MAT2A (0.38) MAT2AHTTKDM4EPDE11ACSF1R
SCHEMBL8287433 0.82 RAB9A (0.38) HTTKDM4EPDE11ACSF1RGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed